By proceeding, you agree to our Terms of Use and Privacy Policy.
James Bowman is part of the founding team and Head of Discovery at AI Proteins. He did his PhD at the University of Southern California engineering a viral GPCR and using it for nanobody discovery. After that, he joined the Protein Design Lab at the Institute for Protein Innovation where he developed tumor-targeting mini proteins. Now, at AI Proteins, he leads library construction, display screening, and deep sequencing efforts to engineer mini protein binders against therapeutic targets.
Talks About #protein #management
Preferred Locations #Northamerica
Next Generation Protein Therapeutics Summit is excited to announce a brand new pre-conference workshop day plus a new main conference day to the 2023 agenda.
